IRF1 and prostate cancer: PARP9 is such a protein, which promotes STAT1 activation and pro-inflammatory gene expression in IFNγ-treated macrophages15 as well as in pancreatic epithelial and cancer cells57, although PARP9 has been shown to inhibit STAT1 induction of IRF1 in prostate cancer cells58.